Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7941

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907941)

Venlafaxine Hydrochloride USP 75 mg extended-release capsules packaging label from A-S Medication Solutions. The label indicates a quantity of 30 capsules, storage instructions at 68 to 77 degrees Fahrenheit, and includes the product NDC 50090-7941. The label also notes the product form as extended-release capsules for oral use.*

FDA Label Image

Figure (Venlafaxine Fig1)

Pharmacokinetic chart depicting fold change and 90% confidence intervals for venlafaxine and its metabolite ODV in special populations including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism (poor/extensive metabolizer), age over 60 years, and gender differences. Variables shown are analyte concentration (Cmax and AUC) relative to a reference value.*

FDA Label Image

Figure (Venlafaxine Fig2)

A scatter plot chart depicting the fold change and 90% confidence intervals of venlafaxine pharmacokinetic parameters (Cmax and AUC) upon interaction with various drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value and the y-axis lists interacting drugs with analytes and pharmacokinetic markers. Data points include open and closed circles representing different measures of venlafaxine exposure.*

FDA Label Image

Figure (Venlafaxine Fig3)

A chart displaying the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes when interacting with drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents the change relative to the reference value, ranging from 0 to 3.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement including the methoxy-substituted aromatic ring, cyclohexanol moiety, and dimethylaminoethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.